×
戻る Agenda
Session 4 : Considering the Price and Economic Viability of Regenerative Medicine Products
Session Chair(s)
Kiyoshi Okada, MD, PhD
Professor , Deputy Director, Regenerative Medicine Support Office, Future Medica
the University of Osaka & the University of Osaka Hospital, Japan
Akiko Ikeda, RPh
PRIMO, External Researcher/Consultant
National Cancer Center, Japan
Speaker(s)
Drug Lag & Loss in New Modalities
Takeshi Yanagimoto
Boston Consulting Group, Japan
Managing Director & Partner
Industrialization of Regenerative Medicine for the Global Market
Keita Komatsu
Ministry of Economy, Trade and Industry (METI), Japan
The Value and Price of Regenerative Medicine Products (from the Industry’s Perspective)
Hiroyuki Kanoh
MITSUI FUDOSAN Co., LTD, Japan
Senior Adviser, Laboratory & Office Group
Masayo Takahashi
Kobe City Eye Hospital / VCCT Inc., Japan
President